A web-blog (formerly known as Stu's Views and MS News), now published by MS Views and News, a patient advocacy organization. The information on this blog helps to Empower those affected by Multiple Sclerosis globally, with education, information, news and community resources.
~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.
Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Thursday, October 3, 2013
Approval of Phase I Stem Cell Study in Progressive MS
The stem cell research division of the Tisch MS Research Center of New York has announced the FDA approval of a Phase I stem cell study in individuals with progressive MS. The study will use a patient's own stem cells, taken from his or her bone marrow, in an open label, Phase I clinical trial. According to the center's news article, approximately 20 progressive MS patients, recruited from the existing patient population of the International Multiple Sclerosis Management Practice (IMSMP), will be initially enrolled.
The article also notes that the Tisch MS Research Center stem cell trial is the first of its kind in the United States and incorporates several key advantages in terms of the type of stem cells being used and how they are administered (via multiple rounds of treatment into the cerebrospinal fluid). The center states that this FDA approval is the culmination of more than a decade of research into the therapeutic potential of stem cells for MS patients. Their initial ("proof of concept") studies with an animal model of MS showed that the injected stem cells migrated to areas of demyelination and may have affected the rate of repair